Real-world feasibility of the VARC-recommended multiparametric approach for the assessment of post-TAVI aortic regurgitation by Abdelghani, M. (Mohammad) et al.
International Journal of Cardiology 223 (2016) 220–221
Contents lists available at ScienceDirect
International Journal of Cardiology
j ourna l homepage: www.e lsev ie r .com/ locate / i j ca rdCorrespondenceReal-world feasibility of the VARC-recommended multiparametric
approach for the assessment of post-TAVI aortic regurgitationMohammad Abdelghani a, Ernest Spitzer b, Ben Ren b,c, Patrick W.J.C. Serruys d, Osama I.I. Soliman b,c,⁎
a Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
b Cardialysis Clinical Trials Management and Core Laboratories, Rotterdam, The Netherlands
c Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands
d The International Centre for Circulatory Health, NHLI, Imperial College London, United Kingdom⁎ Corresponding author at: Cardialysis Clinical T
Laboratories, Rotterdam, The Netherlands.
E-mail address: o.soliman@erasmusmc.nl (O.I.I. Solima
http://dx.doi.org/10.1016/j.ijcard.2016.08.210
0167-5273/© 2016 The Authors. Published by Elsevier Irea r t i c l e i n f oArticle history:
Received 6 August 2016
Accepted 11 August 2016
Available online 11 August 2016
Keywords:
needed for regurgitation volume (RV) and fraction (RF) calculation
were recorded in 66% of cases.
Out of 1240 echocardiogramswith recorded SAX color Doppler, 90%
were analyzable for circumferential extent (CE) of PVL jet (if present) or
sufﬁciently reliable to exclude AR (if not present). Aortic ﬂowmodal ve-
locity envelop from either suprasternal or subcostal view was clearAortic valve stenosis
Aortic valve incompetence
Aortic regurgitation
Transcatheter aortic valve replacement
EchocardiographyFor a diagnostic test to be clinically useful, in addition to accuracy
(i.e. representation of the true disease severity) and precision (i.e. re-
producibility on rerating), it needs also to be feasible. According to
Oxford dictionary, “feasible” is deﬁned as being “possible and practical
to do easily or conveniently”.
The valve academic research consortium (VARC) II-recommended
multiparametric approach, although became the standard approach
for aortic regurgitation (AR) adjudication after transcatheter aortic
valve implantation (TAVI), is so far based on the experts' consensus
rather than on an evidence of validity. The accuracy and precision of
this approach have been challenged in a handful number of studies [1,
2] but no data are available to describe its feasibility.
Between March 2012 and April 2015, 1255 consecutive 2D-
transthoracic echocardiograms from ﬁve TAVI registries were provided
(by 94 centers in 4 continents) to the core lab for adjudication. A total of
18 parameters of AR severity were examined in all echocardiograms for
both availability and analyzability (i.e. conﬁdence of measurement).
Based on all available parameters, AR was classiﬁed as Ntrace in 822
studies (65.5%) and as none/trace in 433 (34.5%). Regurgitation was
transvalvular in only 7%, while the remainder was paravalvular (PVL).
Among the four VARC-II criteria, parasternal short-axis view (SAX)
color Doppler had the highest acquisition rate (99%) while aorticrials Management and Core
n).
land Ltd. This is an open access articldiastolic ﬂow reversal (DFR) had the lowest (57%). All the parameters
enough to allow proper assessment of DFR duration and end-diastolic
velocity (if applicable) in 68% of recordings. RV and RF were analyzable
in 65% of recordings. While left ventricular outﬂow tract stroke volume
was almost always feasible to assess (97%), right ventricular outﬂow
tract (RVOT) stroke volume was the main limitation of quantitative
Doppler. RVOT diameter was analyzable in 71%, RVOT velocity-time in-
tegral in 82% of recordings, and both in 68%.
Overall, a combination of VARC-II parameters was feasible in 53% of
cases. In 40%, AR gradingwas based on a single reliable VARC-II criterion
(most commonly, SAX color Doppler) supported by non-VARC parame-
ters (color Doppler from long-axis views and continuous-wave Dopp-
ler) and in 7% of cases, AR gradingwas based on non-VARC parameters.
AR is a common complication of TAVI [3–5] and, owing to its nega-
tive impact on clinical outcomes [3–5], it has become an end-point in
TAVI trials, an important determinant of procedural success, and a
benchmark used for comparing different devices and device iterations.
Moreover, accumulating data on structural valve deterioration [6] at
long-term further emphasize the importance of a precise judgment of
AR severity and evolution. Based on currently available schemes for
quantitation, basically based on the VARC-II criteria, the data on the
rate, the fate and the clinical signiﬁcance of AR after TAVI are consider-
ably variable [3,5,7,8].
Our observations refer to a limited applicability of the VARC-II ap-
proach under the current acquisition practice. Our ﬁndings are consis-
tent with signals from other core labs. In a sample of echocardiograms
from the randomized PATNER trial, a consortium of core lab directors
analyzed 100 studies. The consortium's level of conﬁdence in AR grad-
ing was high in 62 studies. Overall, 13% of post-TAVI echocardiograms
were of inadequate quality for AR to be reliably adjudicated according
to the VARC-recommended multiparametric approach [2]. Reasons for
inability to interpret most frequently involved missing views
preventing accurate interpretation of the severity of AR [2].
The VARC-III document is awaited, and for this to be more practical,
it has to take into account the feasibility of the component parameters.e under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
221CorrespondenceSources of funding and conﬂicts of interest
None.
References
[1] G.R. Hartlage, V.C. Babaliaros, V.H. Thourani, et al., The role of cardiovascularmagnetic
resonance in stratifying paravalvular leak severity after transcatheter aortic valve re-
placement: an observational outcome study, J. Cardiovasc. Magn. Reson. 16 (2014)
93.
[2] R.T. Hahn, P. Pibarot, N.J. Weissman, L. Rodriguez, W.A. Jaber, Assessment of
paravalvular aortic regurgitation after transcatheter aortic valve replacement: intra-
core laboratory variability, J. Am. Soc. Echocardiogr. 28 (2015) 415–422.
[3] G. Athappan, E. Patvardhan, E.M. Tuzcu, et al., Incidence, predictors, and outcomes of
aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and
systematic review of literature, J. Am. Coll. Cardiol. 61 (2013) 1585–1595.[4] R.T. Hahn, P. Pibarot, W.J. Stewart, et al., Comparison of transcatheter and surgical
aortic valve replacement in severe aortic stenosis: a longitudinal study of echocardi-
ography parameters in cohort A of the PARTNER trial (placement of aortic transcath-
eter valves), J. Am. Coll. Cardiol. 61 (2013) 2514–2521.
[5] S. Kodali, P. Pibarot, P.S. Douglas, et al., Paravalvular regurgitation after transcatheter
aortic valve replacement with the Edwards sapien valve in the PARTNER trial: char-
acterizing patients and impact on outcomes, Eur. Heart J. 36 (2015) 449–456.
[6] D. Mylotte, A. Andalib, P. Theriault-Lauzier, et al., Transcatheter heart valve failure: a
systematic review, Eur. Heart J. 36 (2015) 1306–1327.
[7] J.K. Oh, S.H. Little, S.S. Abdelmoneim, et al., Regression of paravalvular aortic regurgi-
tation and remodeling of self-expanding transcatheter aortic valve: an observation
from the CoreValve U.S. pivotal trial, JACC Cardiovasc. Imaging 8 (2015) 1364–1375.
[8] M.B. Leon, C.R. Smith, M.J. Mack, et al., Transcatheter or surgical aortic-valve replace-
ment in intermediate-risk patients, N. Engl. J. Med. 374 (2016) 1609–1620.
